Brazil Habeas Corpus to ANVISA AE: 2027 Cannabis Transition Deadline

Cultivating under a court order today? Here is what the 5 August 2027 ANVISA transition deadline actually requires.

Brazil’s medicinal cannabis cultivation has, for years, lived almost entirely inside the courts. Patient cultivators, family caregivers, and patient associations grew cannabis under individual habeas corpus orders, salvo-conduto decisions, and writs of mandamus because ANVISA had not issued a cultivation framework. Article 28 of RDC 1.013/2026 sets a single hard deadline for everyone in this position: 5 August 2027. By that date, every cultivator currently operating under judicial relief must obtain an Autorização Especial (AE) from ANVISA. After that date, a habeas corpus alone is no longer enough.

This guide explains how the transition pathway works, who it covers, what documentation carries forward into an AE petition, what new obligations attach, and what happens to operators who miss the window. For the broader framework and the AE petition process, see the pillar guide.

Why Does Brazil Have a Habeas Corpus Cannabis Cultivation System in the First Place?

For more than two decades, Brazilian law treated cultivation of Cannabis sativa L. as a controlled-substance offence under Portaria SVS/MS nº 344/1998. ANVISA never published a domestic cultivation rule, so patients could only access cannabis-based products through importation. The courts filled the gap. Individual patients and family caregivers filed habeas corpus petitions arguing that personal medicinal cultivation, conducted under a physician’s prescription and in proportion to the patient’s needs, should not expose them to criminal prosecution. By 2024, thousands of individual orders had been granted, and patient associations such as APEPI and Abrace operated under collective judicial protection to supply cannabinoid extracts to their members at cost.

In November 2024, the Superior Tribunal de Justiça (STJ) issued a unanimous decision in Recurso Especial nº 2024250/PR ordering ANVISA to publish a regulatory framework for domestic medicinal cultivation within a fixed deadline. RDC 1.013/2026, published in the Diário Oficial da União on 3 February 2026, is the direct response, and Article 1 expressly cites the STJ ruling. Article 28’s transition rule exists because the existing universe of judicial cultivators had to be brought into the new framework rather than abandoned.

What Is Article 28 of RDC 1.013 and What Does It Mean for Current Cultivators?

Article 28 is short and is the only provision addressing operators already cultivating under court orders. Read it carefully.

In English: establishments that were cultivating Cannabis sativa L. by virtue of a judicial decision before the publication of RDC 1.013 have until 5 August 2027 to bring their operations into compliance and obtain an AE. The sole paragraph adds an important guard-rail: plant material produced during the transition window may only be supplied for medicinal and research purposes, on the same terms as the rest of RDC 1.013.

Three things are doing work in that text. First, the date is fixed at 5 August 2027, one year after the rest of RDC 1.013 takes effect on 4 August 2026. Second, the transition is conditioned on holding a prior judicial decision; cultivators without a court order do not get the runway. Third, material grown under a habeas corpus during the transition window must move through the same medicinal and research chain as material produced under an AE.

Who Qualifies for the 2027-08-05 Transition Pathway?

Article 28’s plain text covers any establishment cultivating Cannabis sativa L. by virtue of a judicial decision issued before 3 February 2026. In practice, three operator categories sit inside that definition.

Individual patient cultivators and family caregivers

Most habeas corpus orders in Brazil are individual: a patient (or a parent or spouse cultivating for them) holds a personal judicial decision authorising cultivation in proportion to the prescribed treatment. Article 28 covers these operators provided the order was issued before 3 February 2026. The conservative reading is that any cultivation the holder intends to continue past 5 August 2027 must move into the AE framework or into the RDC 1.014 sandbox where eligibility allows.

Patient associations operating under collective judicial protection

APEPI, Abrace Esperança, and other patient associations growing for their members under collective habeas corpus orders are squarely covered by Article 28. Associations have two pathways: an AE under RDC 1.013 (suitable for associations with the scale and infrastructure of a commercial-grade operation), or the regulatory sandbox under RDC 1.014, which is designed for small-scale and association-driven activity and is the more natural fit for most non-commercial patient associations.

Companies operating under preventive habeas corpus

A smaller number of Brazilian companies obtained preventive habeas corpus orders allowing them to begin cultivation in anticipation of a regulatory framework. These operators move into the commercial AE channel under RDC 1.013 with relatively few changes to their business model.

Who is NOT covered

Cultivators who began operating without a judicial decision, or whose court order was issued on or after 3 February 2026, are not within the scope of Article 28. They must obtain an AE through the ordinary route. The transition window does not retroactively legalise unauthorised cultivation.

What Documentation Carries Over From a Habeas Corpus to an AE Filing?

RDC 1.013 does not give judicial cultivators a discount on the AE petition itself. The same six Article 4 documents are required: geographic coordinates, photographs of the cultivation areas with measurements, a yield estimate per hectare and square metre, propagation-material origin documentation, an organisational chart, and a monitoring and control plan. The underlying AE criteria are defined by RDC 16/2014.

What changes for habeas corpus operators is that much of the underlying evidence already exists. Cultivators under court protection have typically maintained at least some of:

• The court order itself, identifying the cultivator, the prescribing physician, and the patient (or in the case of an association, the protected member class)
• Site documentation prepared for the court (photographs, addresses, security descriptions)
• Propagation-material acquisition records (seeds, clones, or in-house genetic stock)
• Cultivation logs kept to demonstrate compliance with the terms of the court order
• Laboratory analyses commissioned to demonstrate the THC content of harvested material

The substantive content overlaps. Site photographs satisfy part of Article 4, §1, II. Acquisition records support Article 14 (genetic-origin documentation). Cultivation logs feed into the Article 15 traceability procedure. Laboratory analyses align with Article 16 per-lot THC analysis. The transition exercise is largely a documentation reformat rather than a fresh build. The piece almost no judicial cultivator has on hand is the environmental monitoring and control plan (Article 4, §1, VI), which addresses environmental release prevention, security against diversion, and the Article 18 destruction protocol for material above 0.3% THC. That plan typically has to be drafted from scratch.

What New Compliance Obligations Attach Under RDC 1.013?

Court orders varied widely in their conditions. RDC 1.013 standardises the obligations across all AE holders. The substantive duties that attach the moment an operator moves from judicial protection to an AE include:

• Article 15 batch traceability: every lot must be identified by lot number, cultivation stage, start date, variety, and quantity of plants.
• Article 16 per-lot THC laboratory analysis: every harvested lot must carry a documented THC test result performed by either an authorised in-house laboratory or a Rede Brasileira de Laboratórios Analíticos em Saúde (Reblas) member.
• Article 18 destruction protocol with 48-hour notification: any plant testing above 0.3% THC must be secured, destroyed, and reported to the local sanitary authority within 48 hours, with a documented investigation into the root cause.
• Articles 19 and 21 quarterly and annual BSPO reporting: the Balanço Trimestral and Anual de Substâncias Psicoativas e Outras Sujeitas a Controle Especial, plus the Production Estimate, on the schedule defined by Portaria 344/1998 and Portaria 6/1999.
• Annual AE renewal under RDC 16/2014 Article 19: the AE is valid for one year from the DOU publication date of the initial grant and must be renewed annually, with the petition filed 60 to 180 days before expiration (RDC 16/2014 Art. 20).
• Boas Práticas Agrícolas (BPA/GAP): IN 130/2022, WHO Good Herbal Processing Practices, and MAPA’s separate agronomic requirements all attach by reference under Article 26.

A note on the twin thresholds: RDC 1.013 caps cultivation at THC at or below 0.3% (dry weight, in the inflorescences). RDC 1.011 sets a separate scheduling threshold of 0.2% under Portaria 344, determining whether finished material is dispensed against a yellow (List A3) or blue (List B1) prescription. Two numbers, two regulatory purposes, both required in the compliance model.

What Happens If the 2027 Deadline Is Missed?

Article 28 does not contain a grace period. On 6 August 2027, cultivators who have not obtained an AE are no longer covered by the regulatory framework. The habeas corpus does not disappear, but it stops operating as compliance cover under RDC 1.013 because the resolution expressly contemplated the transition. Continued cultivation without an AE is an infração sanitária under Article 29, which incorporates the administrative penalties of Lei nº 6.437/1977: warnings, fines, seizure of plant material, interdiction of the establishment, and cancellation of authorisations.

The practical implication is that the petition cannot wait until the deadline. RDC 1.013 takes effect on 4 August 2026 and AE petitions can be filed from that date. The four-ministry coordination committee (ANVISA, Ministry of Justice, Ministry of Health, MAPA) is designed to surface non-compliant cultivation through agronomic, sanitary, and security inspections. Transitioning operators should plan to file in the second half of 2026 to leave room for clarifications, document requests, and inspection scheduling before the August 2027 cut-off.

Frequently Asked Questions

Transitioning From Habeas Corpus to ANVISA AE?

Built for the Article 28 transition: judicial documentation carry-over, RDC 1.013 compliance overlays, and AE-ready records for the 5 August 2027 deadline. See how transitioning operators consolidate.

REQUEST DEMO